Celerity Introduces Next Generation Mass Flow Controllers for Semiconductor Device Manufacturing

Celerity, Inc., a technology leader in precision instruments and advanced gas and liquid delivery solutions for the global semiconductor, solar and electronics industries, announced today the introduction of its new GF100 series mass flow controller (MFC) designed to precisely measure, monitor and control ultra high purity process gas chemistry in semiconductor device and solar cell manufacturing processes. The new Celerity GF100 series MFC is a highly configurable platform featuring Celerity's second generation proprietary pressure transient insensitive flow technology, which improves process control, reduces cost of ownership, and eliminates complexity of inventory management.

The new Celerity GF100 series mass flow controller product family features a number of key benefits including high accuracy, reproducible gas measurement, control from advanced digital architecture, in situ electronic reconfiguration of gas and flow range for maximum process flexibility and optimization, pressure transient insensitive flow technology design (enables significant cost and size reduction of high purity gas delivery systems), and intelligent embedded diagnostics, service port and software for simple and efficient on-tool maintenance.

"Celerity is a market leader in advanced digital ultra high purity mass flow controllers and an industry pioneer in pressure transient insensitive MFCs. By leveraging our extensive experience in gas flow control, the GF100 series is a continuous improvement update (CIP) of our market leading precision mass flow controllers, providing customers with a seamless RoHS compliant upgrade for enhanced process control and lower cost of ownership," said David Somo, Celerity's Senior Vice President of Sales and Marketing.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.